Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequent side
effects caused by antineoplastic agents, with a prevalence from 19% to over 85%. Clinically …

Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …

Neurotoxic anticancer drugs, such as platinum-based anticancer drugs, taxanes, vinca
alkaloids, and proteasome/angiogenesis inhibitors are responsible for chemotherapy …

With a 3‐fold increase in the number of cancer survivors noted since the 1970s, there are
now over 28 million cancer survivors worldwide. Accordingly, there is a heightened …

Objective Complex phenotypes captured on histological slides represent the biological
processes at play in individual cancers, but the link to underlying molecular classification …

Chemotherapy-induced neuropathy and its association with quality of life among 2-to 11-year
colorectal cancer survivors: results from the population-based PROFILES registry Page 38 …

Platinum‐induced peripheral neurotoxicity (PIPN) is a common side effect of platinum‐
based chemotherapy that may cause dose reduction and discontinuation, with oxaliplatin …

Importance Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating adverse
effect of neurotoxic cancer treatments including taxanes and platinum agents. Limited …

Purpose The aim of this study was to systematically review the literature on the influence of
oxaliplatin administration (eg cumulative dose, dose intensity, number of cycles and …

Background With improved survivorship rates for colorectal cancer (CRC), more CRC
survivors are living with long-term disease and treatment side effects. Little research exists …